V. Panichi et al., CALCITRIOL MODULATES IN-VIVO AND IN-VITRO CYTOKINE PRODUCTION - A ROLE FOR INTRACELLULAR CALCIUM, Kidney international, 54(5), 1998, pp. 1463-1469
Background Several immunomodulatory properties of calcitriol are curre
ntly known, however, only little information is available regarding th
e in vivo and in vitro effects of calcitriol on cytokine production in
chronic renal failure. Methods. To study the in vitro effect of calci
triol on lipopolysaccharide (LPS)-induced cytokine production, periphe
ral blood mononuclear cells (PBMC, 2.5 ml/ml) from 12 chronic dialytic
(KD), 15 undialyzed chronic renal failure (CRF) patients and 10 norma
l subjects (N) were incubated at 37 degrees for 12 hours with 100 ng o
f LPS (E. coil and P. maltofilia). Increasing doses of calcitriol from
10(-10) to 10(-9) M were added and cell associated TNF-alpha and IL-1
beta were determined by immunoreactive tests after three freeze-thaw
cycles. The intradialytic TNF-alpha and IL-1 beta production were eval
uated in vivo in 12 HD patients before and after three months of intra
venous calcitriol treatment (6 mu g/week). Intracellular calcium [Ca+](i) was determined on PBMC with a cytofluorimetric assay using FLUO-3
AM as the indicator. Results. In vitro, TNF-alpha increased from 3.6
+/- 1.9 pg/cell to 1797 +/- 337 in N, from 4.5 +/- 1.7 to 1724 +/- 232
in CRF and from 3.4 +/- 2.3 to 1244 +/- 553 in HD after the LPS stimu
lus. The production of TNF-alpha was inhibited by calcitriol in a dose
-dependent manner [LPS + Vit.D-3, 100 ng, 2.9 +/- 2.1 in N, 3.7 +/- 1.
9 in CRF and 3.4 +- 1.7 in HD; LPS + Vit.D-3 50 ng, 263 +/- 296 (N), 6
.73 +/- 11(CRF), 38 +/- 28 (HD); LPS + Vit.D-3 25 ng = 873 +/- 583 (N)
, 325 +/- 483 (CRF), 588 +/- 507 (KD); LPS + Vit.D-3 12.5 ng, 954 +/-
483 (N), 912 +/- 510 (CRF), 875 +/- 527 (HD)]. Comparable data were ob
served on IL-1 beta production. In vivo, the intradialytic TNF-alpha i
ncrease (from 8.5 +/- 2.3 to 19 +/- 5.6 pg/2.5 x 10(6) cell) during he
modialysis was markedly reduced after calcitriol therapy (from 6.6 +/-
3.1 to 11 +/- 4.7). [Ca++](i) decreased from 105 +/- 25 to 72 +/- 18
nM (P < 0.05) and a positive correlation between cytokine levels and [
Ca++](i) was found (r = 0.79; P < 0.001). Conclusions. The in vitro in
crease of cell-associated cytokine after LPS challenge was inhibited b
y calcitriol in a dose-dependent manner. These data suggest a possible
in vivo modulatory effect of calcitriol therapy on cytokine productio
n in hemodialysis.